MONOCLONAL ANTIBODIES
Abyntek counts on an international scientific and technical team with extensive experience in the development of monoclonal antibodies by hybridoma technology. The advantages of our services include:
- Feasibility study
- Personalized advice
- Immunization and antibody development strategy planning based on each customer´s needs